E.E. Geduld’s Foundation Medicine, Inc. FMI Stock Holding History

E.E. Geduld’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-10,000	Closed	-$238K	–	358
2013 Q4	$238K	Sell	10,000 -15,400	-61%	-$430K	0.11%	181
2013 Q3	$1.01M	Buy	+25,400	New	+$935K	0.61%	31

Other funds holding FMI

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CCM

Cupps Capital Management Chicago, Illinois $231M AUM 49.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

E.E. Geduld's FMI Position: Q1 2014 in Review

E.E. Geduld sold out of Foundation Medicine, Inc. (FMI) in Q1 2014, closing a stake of 10,000 shares — an estimated $238K sold.

E.E. Geduld first reported a position in FMI in Q3 2013 and held it in 2 quarters. The position peaked at $1.01M in Q3 2013. 90 funds tracked by Wall St. Rank hold FMI as of Q1 2014.

E.E. Geduld reported no remaining Foundation Medicine, Inc. position as of Q1 2014 after selling out during the quarter.
E.E. Geduld sold 10,000 Foundation Medicine, Inc. shares in Q1 2014, an estimated $238K.
E.E. Geduld first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 2 quarters.
E.E. Geduld's Foundation Medicine, Inc. position peaked at $1.01M in Q3 2013.
90 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2014.

Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.